# Maccura

> Maccura is a VC fund in Chengdu backing Medical, Health Care and Biotechnology. See 3 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Chengdu, China
- Total investments: 3
- Last investment: Nov 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/maccura-biotechnology/
- Website: http://www.maccura.com/en
- Facebook: https://www.facebook.com/Maccura-Biotechnology-722018384638438/

Maccura is a VC fund in Chengdu focused on Medical and Health Care. Maccura Biotechnology Co., Ltd. was incorporated in 1994. It focuses on In-Vitro Diagnostic reagents’ development, manufacture, marketing and service.Maccura is an IVD integration company of research & development, production, sales and services. Maccura has the best research & development team around the world which is led by severalscientists. Maccura has established five product and technology development platforms which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis. We become the first enterprise member at IFCC. As an IVD company, Maccura is the first batch to build the enzymatic reference laboratory, and traceable results of maccura’s diagnostic products have reached the international advanced level.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Genetics | 1 | 33% |
| Life Science | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nutshell Bio | Nutshell Bio is a biotechnology company focused on life science research and human health through genome testing. |  | Series A | Nov 30, 2021 | http://www.bioguoke.com/#/ |
| Shenzhen bode Zhi Yuan Biotechnology | Based on the world’s leading microfluidic integrated chip technology, R&D, production and sales of " All-in-One " and " Sample in Result out " fully integrated automatic molecular diagnostic products, fully enclosed chip design, prevent aerosol cross-contamination, and bid farewell to molecules In the era when laboratoriesneed independent construction, we reshape the MDx industry pattern of molecular diagnostics . |  | Seed | Nov 02, 2021 | http://www.broadx.com.cn/page85 |
| Mega Genomics | mega genomics provides genetic testing services for public health management, medical clinics and scientific research services. | $1.4M | Series A | Dec 02, 2016 | http://megagenomics.cn |

3 of 3 investments shown.

## Co-investors
- [Century Golden Resources Group](https://shizune.co/investors/profile/century-golden-resources-group) — VC Fund, 1 deal together
- [Innovita Biological Technology](https://shizune.co/investors/profile/innovita-biological-technology) — VC Fund, 1 deal together
- [Linghao Touzi](https://shizune.co/investors/profile/linghao-touzi) — VC Fund, 1 deal together
- [New Hope Sichuan Venture Capital Fund](https://shizune.co/investors/profile/new-hope-sichuan-venture-capital-fund) — VC Fund, 1 deal together
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does Maccura invest in?

Maccura invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Maccura last invest?

The most recent investment recorded for Maccura closed in Nov 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co